RCBTB1 and sarcoma: To circumvent this lack of information, current drugs for pleomorphic sarcoma treatment [2] (doxorubicin, gemcitabine, and docetaxel) were screened and apoptotic responses of LMS cell lines (the main histotype affected by RCBTB1 deletions) with induced RCBTB1 expression were measured.